Orchestra BioMed Holdings (OBIO) Other Non Operating Income (2022 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Other Non Operating Income came in at -$35000.0 in Q1 2026, down 218.18% on a QoQ basis from -$11000.0 in Q1 2024.
Orchestra BioMed Holdings (OBIO) Other Non Operating Income (2022 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 3 years of Other Non Operating Income data on file, last reported at -$35000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income changed N/A year-over-year to -$35000.0 in Q1 2026; TTM through Mar 2026 was -$35000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $254000.0, up 2409.09% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$35000.0, down from -$11000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for OBIO reached as high as $682000.0 in Q2 2022 and fell as low as -$35000.0 in Q1 2026.
- Historically, Other Non Operating Income has averaged $212000.0 across 3 years, with a median of -$11000.0 in 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Jun 30, 2022 | 682,000.00 |